BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Codexis to Hold Third Quarter 2019 Conference Call on November 5

  Codexis, Inc., a leading protein engineering company, announces that it will report third quarter 2019 financial results after market close on Tuesday, November 5, 2019.

  October 29, 2019

   · 

  1 min read
• Business

  Antares Pharma to Report Third Quarter 2019 Financial and Operating Results

  Antares Pharma, Inc. announced it will release its third quarter 2019 financial results and recent operating progress before the market opens on Tuesday, November 5, 2019.

  October 29, 2019

   · 

  4 min read
• Business

  Axsome Therapeutics to Report Third Quarter 2019 Financial Results on November 7, 2019

  Axsome to host conference call and webcast on Thursday, November 7, 2019 at 8:00 AM Eastern Time

  October 29, 2019

   · 

  4 min read
• Deals

  AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG Trial

  AMAG Pharmaceuticals, Inc. announced that NASDAQ has halted trading of the company’s common stock.

  October 29, 2019

   · 

  2 min read
• BioLineRx to Deliver Oral Presentation at ESMO Immuno-Oncology Congress 2019

  Proffered paper presentation to highlight new clinical data from a Phase 2a study evaluating BL-8040 in combination with pembrolizumab and chemotherapy in metastatic pancreatic cancer

  October 29, 2019

   · 

  4 min read
• Drug Development

  Sutro Biopharma Presents Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002 Antibody-Drug Conjugate in Patients with Advanced Ovarian Cancer

  Data is being presented as a poster today at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference in Boston

  October 29, 2019

   · 

  7 min read
• Business

  Provention Bio to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 5, 2019

  Provention Bio, Inc., a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, announced that it will report its third quarter 2019 financial results on Tuesday, November 5, 2019.

  October 29, 2019

   · 

  1 min read
• Business

  Disc Medicine Expands Pipeline Focused on Hepcidin Pathway

  Enters into exclusive agreement with AbbVie for series of Hemojuvelin Antagonist Monoclonal Antibodies

  October 29, 2019

   · 

  1 min read
• Business

  Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production

  Disc Medicine, a hematology company applying new insights in hepcidin biology to develop therapies that restore red blood cell production in hematologic diseases, announced the completion of a $50 million Series A financing.

  October 29, 2019

   · 

  4 min read
• Business

  DaVita Selects its Next Chief Accounting Officer

  DaVita Inc. announced the selection of its next Chief Accounting Officer, John Winstel.

  October 29, 2019

   · 

  2 min read